AI medical-data platform for lung and heart disease drug development.
| Date | Round | Amount |
|---|---|---|
| Jul 2026 | Series B Qureight, a UK imaging company for clinical trials, raised a 20 million dollar Series B led by Molten Ventures with existing backers, taking total funding above 27 million euros. The capital will fund an AI imaging lab and new disease models in areas such as asthma and pulmonary hypertension. | $20M |
| Apr 2024 | Series A UK techbio Qureight raised an $8.5M Series A led by Hargreave Hale AIM VCT for its AI medical-imaging platform. | $8.5M |
| Feb 2022 | Seed Qureight raised GBP1.5M seed led by Playfair Capital for its imaging-analytics platform. | $1.5M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.